Innovation Pharmaceuticals Inc (IPIX)

[rrr1]

PR earlier last week said "Pierce the Envelope" So Brilacidin is designed to get inside the COVID-19 cellular structure and attack from within. With or without added assist from Anti-Biotic IDK. But we have the best in the world at RBL and a Top Expert led University Bio Lab. We have to trust they are going around the clock and ensuring B is not taking out healthy cells too. That is the key they have to confirm no collateral damage.

2 Phase Trials say it won't lets see if these CDC, FDA, and independent experts agree.